Compare, Analyse Cadila Healthcare with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ACTAVIS (US) - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   ACTAVIS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
ACTAVIS
Dec-18
CADILA HEALTHCARE/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs35214,122-   
Low Rs2079,473-   
Sales per share (Unadj.) Rs139.23,464.0-  
Earnings per share (Unadj.) Rs11.8-1,115.8-  
Cash flow per share (Unadj.) Rs18.6365.0-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs101.414,287.5-  
Shares outstanding (eoy) m1,023.74332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.03.4 58.9%   
Avg P/E ratio x23.7-10.6 -224.6%  
P/CF ratio (eoy) x15.032.3 46.6%  
Price / Book Value ratio x2.80.8 333.9%  
Dividend payout %29.80-   
Avg Mkt Cap Rs m286,0333,923,754 7.3%   
No. of employees `00013.416.9 79.3%   
Total wages/salary Rs m24,1450-   
Avg. sales/employee Rs Th10,632.768,173.7 15.6%   
Avg. wages/employee Rs Th1,801.20-   
Avg. net profit/employee Rs Th898.5-21,958.8 -4.1%   
INCOME DATA
Net Sales Rs m142,5311,152,135 12.4%  
Other income Rs m1,13922,033 5.2%   
Total revenues Rs m143,6701,174,168 12.2%   
Gross profit Rs m24,19830,192 80.1%  
Depreciation Rs m6,965492,513 1.4%   
Interest Rs m3,41866,485 5.1%   
Profit before tax Rs m14,954-506,773 -3.0%   
Minority Interest Rs m2880-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0129,248 0.0%   
Tax Rs m3,198-6,422 -49.8%   
Profit after tax Rs m12,044-371,103 -3.2%  
Gross profit margin %17.02.6 647.9%  
Effective tax rate %21.41.3 1,687.5%   
Net profit margin %8.5-32.2 -26.2%  
BALANCE SHEET DATA
Current assets Rs m87,154472,546 18.4%   
Current liabilities Rs m82,694418,029 19.8%   
Net working cap to sales %3.14.7 66.1%  
Current ratio x1.11.1 93.2%  
Inventory Days Days7120 364.7%  
Debtors Days Days9466 141.5%  
Net fixed assets Rs m133,236130,415 102.2%   
Share capital Rs m1,0240-   
"Free" reserves Rs m102,7330-   
Net worth Rs m103,7574,752,020 2.2%   
Long term debt Rs m32,1461,673,358 1.9%   
Total assets Rs m236,8667,428,488 3.2%  
Interest coverage x5.4-6.6 -81.2%   
Debt to equity ratio x0.30.4 88.0%  
Sales to assets ratio x0.60.2 388.0%   
Return on assets %6.5-4.1 -159.2%  
Return on equity %11.6-7.8 -148.6%  
Return on capital %13.7-4.8 -283.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m38,2480-   
CASH FLOW
From Operations Rs m25,054411,614 6.1%  
From Investments Rs m-10,123226,129 -4.5%  
From Financial Activity Rs m-10,942-706,454 1.5%  
Net Cashflow Rs m3,989-68,368 -5.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.98 Rs / USD

Compare CADILA HEALTHCARE With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: LUPIN  FULFORD INDIA  CIPLA  J.B.CHEMICALS  PANACEA BIOTECH  



Today's Market

Sensex, Nifty Open Higher; Bajaj Finance & UltraTech Cement Top Gainers(09:30 am)

Asian stock markets are trading on a strong note today. The Hang Seng is trading up by 2% while the Shanghai Composite is up 0.6%. The Nikkei is trading higher by 0.4%.

Related Views On News

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks (Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond (Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021 (Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021 (Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CADILA HEALTHCARE SHARE PRICE


Jan 25, 2021 12:04 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

FEATURED VIDEOS

Great vs Good: Which Stock Will Win in 2021?

Safest Assets in 2021 are Not What You Think...

I Combined Stocks & Gold and Saw the Magic Happen

Stocks Could Do Extremely Well, But...

More Featured Videos

MARKET STATS